-
World’s First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center
SHANGHAI, July 6, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has welcomed the world’s first international patient to begin treatment with Satri-cel, the world’s first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to China’s latest oncology innovations. Josh, a 59-year-old patient from New Zealand with advanced…
-
Rare Neuro Emergency after Spinal Tumor Surgery Turns Critical, Ends in Successful Recovery at Zydus Hospital, Ahmedabad
Mother of two, saved after a whirlwind of physical turmoil AHMEDABAD, India, June 26, 2026 /PRNewswire/ — A 35-year-old woman, mother of one, had persistent lower back pain for a very long time. However, in the second pregnancy the pain became relatively severe where even doctors were unable to administer spinal anaesthesia. She delivered a healthy…
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
